Collectively, our results suggest that exosomal EPHA2 derived from HM breast cancer cells promotes breast cancer progression through the AMPK-HIF-1α pathway downstream of Ephrin A1-EPHA2 forward signaling. Here, EPHA2 is linked to breast cancer.